Injective continues to strengthen its institutional presence in the U.S. ETF filings related to INJ (including Canary’s staked proposal with the ticker INJC and the 21Shares filing) are currently under review; INJ futures have been listed on a CFTC-regulated market. The registration of a transfer agent with the SEC, along with ongoing discussions between leadership and the White House, SEC, and CFTC, demonstrate efforts to establish a legal framework for tokenization and on-chain finance. These factors lay the groundwork for access to traditional capital flows, though the timing of specific approvals remains dependent on regulatory progress.